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Abstract Polyomavirus reaches the nucleus in a still encapsi-
dated form, and the viral genome is readily found in association
with the nuclear matrix. This association is thought to be
essential for viral replication. In order to identify the protein(s)
involved in the virus-nuclear matrix interaction, we focused on
the possible roles exerted by the multifunctional cellular nuclear
matrix protein Yin Yang 1 (YY1) and by the viral major capsid
protein VP1. In the present work we report on the in vivo
association between YY1 and VP1. Using the yeast two-hybrid
system we demonstrate that the VP1 and YY1 proteins
physically interact through the D-E region of VP1 and the
activation domain of YY1.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
The mouse polyomavirus (Py) genome encodes three early
tumor antigens (LT, MT and sT) and three late structural
proteins VP1, VP2 and VP3 which make up the viral capsid.
Polyoma late proteins, together with viral DNA and cellular
histones (except H1) are assembled in the host cell nuclei into
virions [1]. The icosahedral capsid is organized by 72 exter-
nally exposed VP1 pentamers with one VP2 or VP3 minor
capsid proteins associated internally with each pentamer [2].
Py VP1 mutants have been isolated and characterized for
modi¢ed host range or tumorigenesis. All of these mutations
are located in the outfacing loops of VP1. The major outfac-
ing protein of the capsid (VP1) has been characterized with
regard to conformational organization and interaction with
the cell membrane receptor [3^5]. According to X-ray di¡rac-
tion studies of its tertiary structure [3], VP1 can be divided
into three modules: an N-terminal arm, an antiparallel
L-sandwich core and a long C-terminal arm. Four loops ema-
nate from the L-sheet framework; three of them (B-C, D-E
and H-I) form closely interacting structures at the outfacing
side of the L-sandwich that are also exposed at the surface of
the capsomeric structure. The long E-F loop is exposed on the
side of the L-sandwich core (and on the side of capsomeres).
The external loops are likely to be the structures involved in
cell receptor recognition by virions [4] and, therefore, to be
the main antigenic determinants. The £exible C-terminal arms
form interpentameric contacts and the basic amino acids of
the N terminal arm are responsible for the non-speci¢c DNA-
binding activity of VP1 [6,7].
The necessity for viral genomes to associate to the nuclear
matrix (NM) in order to be expressed, has been demonstrated
in some DNA tumor viruses such as papilloma and adenovi-
ruses; this association has been shown to be mediated by
proteins encoded by the viral genome [8,9]. For the small
polyomaviruses no such function has been found, although
it has been shown that infecting polyomavirus reaches the
nucleus encapsidated and its genomic DNA readily associates
to the NM [10,11], and this association is thought to deter-
mine the ability of the incoming viral minichromosome to be
transcribed and replicated in the permissive host. Further-
more, it has been shown that in vivo expressed VP1 associates
to the NM [12].
Yin Yang 1 (YY1), a multifunctional cellular transcription-
al regulatory phosphoprotein with predicted molecular weight
44 kDa, migrating on SDS gels as 68 kDa protein, contains
four C2H2-type zinc ¢ngers at the C-terminus responsible for
the sequence-speci¢c DNA binding activity, a glycine-rich re-
pression domain and a N-terminal activation domain. De-
pending on the context, YY1 can activate or repress the tran-
scription of number a of both cellular and viral genes
(reviewed in [13]). Moreover, YY1 has been found to bind
DNA in speci¢c sites, also in the enhancer region of Py
[14]. The protein-protein interaction has an important func-
tion in controlling the activity of YY1 and a number of pro-
teins have been identi¢ed which form complexes with it. An-
other aspect of YY1 function has been unravelled by
demonstration that YY1 is identical to the NM binding pro-
tein NMP-1 [15]. These data imply that YY1 may also be
involved in the association of speci¢c DNA sequences of cel-
lular and viral genes to the NM.
Results from our and other laboratories [16^21] had sug-
gested the possibility that VP1, the major capsid protein,
could determine alterations in the host speci¢city of growth
and tumorigenicity. In order to determine the possible mech-
anisms that allow the encapsidated polyomaviruses that reach
the cell nucleus to associate with the NM, we investigated the
possible role of YY1 in this necessary step of viral function. In
this study we report that YY1 binds in vivo to the capsid
protein VP1. This interaction involves a speci¢c site in the
D-E loop of VP1 and the activation domain of YY1. The
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 1 7 0 - 4
*Corresponding author. Fax: (39)-6-4462891.
E-mail: amati@bce.med.uniroma1.it
1 Present address: Department of Biological Sciences, Columbia
University, New York, NY 10027, USA.
FEBS 23316 3-2-00
FEBS 23316 FEBS Letters 467 (2000) 359^364
possible relevance of VP1-YY1 interaction for the biology of
the viral life cycle is discussed.
2. Materials and methods
2.1. Antibodies
Rabbit polyclonal anti-VP1 (I58) and anti-D-E loop (against
VP1-Leu137^Glu159 peptide) antibodies were kindly provided by R.
Garcea (University of Colorado, CO, USA); mouse monoclonal
anti-VP1 and anti-VP2/3B have been already described [22]; anti-
YY1 (C-20), anti-Gal4-TA (768), anti-p27 (C-19) and anti-Grb-2
(C-23) rabbit polyclonal antibodies were obtained from Santa Cruz
Biotechnology, CA, USA. Secondary, Px-conjugated anti-mouse and
anti-rabbit IgG antibodies were from Bio-Rad Laboratories, Hercules,
CA, USA.
2.2. Py infection and immunoprecipitation
Mouse 3T6 ¢broblast cells were infected with wild type (wt) Py [8]
at a multiplicity of 50 pfu. At di¡erent times post-infection (p.i.) cells
were lysed and lysates were subjected to ultrasonic treatment and
subsequently clari¢ed by centrifugation at 4‡C following Pelicci et
al. [23]. After classical immunoprecipitation, immunocomplexes were
washed three times with cold lysis bu¡er and once with RIPA, eluted
and denatured in Laemmli bu¡er (5 min). Proteins were resolved in
10% SDS^PAGE and transferred onto a nitrocellulose ¢lter. Immu-
nocomplexes were detected using either anti-VP1 or anti-YY1 anti-
bodies and Px-conjugated secondary antibodies [24]. In some experi-
ments secondary non-speci¢c anti-rabbit antibodies (NSA) from
SEVA, a.f. (Prague, Czech Republic) in control immunoprecipitations
were used.
2.3. VP1, VP3 and YY1 over-production in mammalian and insect cells,
and immunoprecipitation
COS cells were co-transfected using the calcium-phosphate tech-
nique [25] with pSVL-VP1 containing the VP1 gene under the SV40
late promoter and with pEB-DELTA:s (kindly provided by A. Felsa-
ni, Istituto Tecnologie Biomediche, Roma, Italy) expressing YY1
from the MSV-LTR promoter. 24 h post-transfection, cells were
pre-incubated for 3 h in methionine-free medium, then labelled 12 h
with 35S-methionine (100 WCi/9 cm dish). SF9 insect cell cultivation,
infection and transfection were performed according to Summers and
Smith [26]. Baculovirus VL-YY1 expressing mouse YY1 from poly-
hedrin promoter was prepared using the pVL1393-YY1 recombinant
transfer plasmid. Insect cells co-infected with baculovirus VL-YY1
and VL-VP1 or with VL-YY1 and Ac-VP1-VP3 (baculovirus prepared
using pAcAB3 transfer vector [27] containing Py VP1 and VP3 genes;
Fostova' et al., manuscript in preparation) or with VL-YY1 and VL-
VP3 were labelled 48 h p.i. by 35S-methionine for 4 h. Lysates of cells
producing YY1, VP1 and/or VP3 were immunoprecipitated with anti-
YY1, anti-VP1 or with anti-VP2/3B antibody. Immunoprecipitates
were resolved on 10% SDS^PAGE and detected by autoradiography
[24].
2.4. In situ fractionation of 3T6 cells
Brie£y, cells attached on the cultivation dish were washed with KM
bu¡er (10 mM MES, pH 6.2, 10 mM NaCl, 1.5 mM MgCl2, 10%
glycerol, 30 Wg aprotinin) and extracted sequentially with bu¡ers I
(KM, 1% NP40, 0.1 mM EGTA, 1 mM DTT), II (KM, 50 Wg/ml
DNase I) and III. (KM, 2 M NaCl, 0.1 mM EGTA, 1 mM DTT).
Washing with KM bu¡er was performed after each extraction [28].
Proteins of extract III were precipitated with methanol-chloroform
[25] and dissolved in Laemmli bu¡er.
2.5. Plasmid constructions
The amino acid sequence of the VP1 used is identical to the wt-Py
sequence of GenBank, accession number P03091 with the following
modi¢cations: G152, W288, V295, S296, S297, L298, E299, K300, F302.
pSVL-VP1: contains the VP1 coding sequence (EcoRV/XbaI-blunt
ended fragment) inserted into pSVL (Pharmacia; XbaI-blunt ended).
pVL1393-YY1: contains the YY1 gene (NcoI-blunt ended/EcoRI)
from pGEM-4Z.DELTA (kindly provided by A. Felsani) inserted
into pVL1393 (Pharmacia) (SmaI/EcoRI). pGBT9-VP1 is composed
of three DNA fragments: (1) the fragment of the 5P part of the VP1
gene (1^761 bp) ampli¢ed using synthetic primers (EcoRI/PstI); (2)
the fragment of the 3P part of the VP1 coding sequence from
pVL1393-VP1 (11) (PstI/BglII) and (3) the plasmid pGBT9 carrying
the GAL4 DNA-binding domain (DNA-BD)) (Clontech; EcoRI/Bam-
HI). Production of the fusion protein in yeast was con¢rmed using
anti-VP1 antibody. pGBT9-VP1144 carries the fragment StuI^NdeI in
pGBT9-VP1 replaced with the corresponding fragment of mutated
VP1-M17 gene containing a SmaI site in position 432 (144 aa) from
pSVL-VP1-M17 (Amati et al., manuscript in preparation); resulting
pGBT9-VP1-M17 was subsequently cleaved by SmaI and SalI, blunt-
ended and religated. pGBT9-VP1140 and pGBT9-VP1136 : pGBT9-
VP1-M17 was linearized by SmaI, treated with BAL31 nuclease,
cleaved by SalI, blunt-ended, religated and electroporated into E.
coli DH5K [24]; the extent of deletions was analyzed by sequencing
(kindly performed by CEINGE, Napoli, Italy). pGBT9-DE118ÿ170 : the
DNA fragment of VP1 (Leu118^Gly170) containing the VP1-D-E loop
(Leu137^Glu159) was ampli¢ed using synthetic primers (EcoRI/PstI),
fused with sequences encoding Gal4bd (Gal4-DNA binding domain)
in pGBT9 (EcoRI/PstI); production of fusion protein in yeast was
con¢rmed using the anti-D-E loop antibody. pGBT9-EF172ÿ248 : con-
structed as described for pGBT9-DE118ÿ170, using ampli¢ed fragment
of VP1 encoding amino acids 172^248. pGAD424-YY1: YY1 gene
from pGEM-4Z.DELTA (EcoRI) was fused with sequences encoding
GAL4 AD (GAL4-activation domain) in pGAD424 (Clontech;
EcoRI), and the production of the fusion protein in yeast was con-
¢rmed using anti-YY1 antibody. YY1 deletions were derived from
pGAD424-YY1 by cleavage with XmaI (pGAD424-YY1200), PstI
(pGAD424-YY189) and EagI (pGAD424-YY1157ÿ414), respectively,
and subsequent religation.
2.6. Yeast strains and methods
S. cerevisiae HF7c (MATa, ura3^52, his3^200, ade2^101, lys2^801,
trp1^901, leu2^3,112, gal4^542, gal80^538, LYS2: :GAL1-HIS3, UR-
A3: :(GAL17-mers)3-Cyc1-lacZ and S. serevisiae SFY526 (MATa,
ura3^52, his3^200, ade2^101, lys2^801, trp1^901, leu2^3,112, canr,
gal4^542, gal80^538, URA: :GAL1-lacZ) strains were previously de-
scribed by Bartel et al. [29]. Yeast transformations with appropriate
plasmids were performed using the lithium acetate technique [30].
Yeast cell cultivation, media, selection of transformants, ¢lter assay
of L-galactosidase activity and detection of HIS3 expression were
performed according to the Clontech ‘Two-Hybrid system manual’.
Fig. 1. In vivo co-immunoprecipitation of VP1 and YY1. 3T6 ¢bro-
blast cells at di¡erent times p.i. were lysed and immunoprecipita-
tions (from 500 Wg of total cell lysate) were performed with either
anti-YY1 antibody or control antibodies speci¢c for exogenous
(KGal4-TA), cytoplasmic (KGrb-2) and nuclear (Kp27) antigens.
After SDS^PAGE separation, proteins were transferred onto nitro-
cellulose membrane and detected using antibodies speci¢c to YY1
and VP1.
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3. Results
3.1. VP1-YY1 association
Our starting point was the detection of VP1 in Py infected
3T6 ¢broblast cell extracts immunoprecipitated with YY1 spe-
ci¢c antibodies, a few hours p.i. and before the onset of viral
replication. Fig. 1 shows the speci¢c coimmunoprecipitation
of VP1 obtained with anti-YY1 antibodies and the lack of
coimmunoprecipitation with antibodies directed against exog-
enous, cytoplasmic or nuclear antigens. In order to determine
if the interaction between VP1 and YY1 is direct, we overex-
pressed both VP1 and YY1 proteins in either mammalian
cells, or recombinant baculovirus systems (Fig. 2A,B). Once
again, the results showed that VP1 and YY1 e⁄ciently coim-
munoprecipitated with YY1-antibodies, thus con¢rming the
interaction. Unexpectedly, under identical conditions, YY1
was not found to coimmunoprecipitate when immunoprecipi-
tates were obtained using anti-VP1 antibodies. This result may
re£ect interference or competition between VP1 antibodies
and YY1 for the same binding site. If this were so, the inter-
action of VP1 with YY1 would be expected to involve regions
of VP1 close to the D-E loop (see below) since the anti-VP1
monoclonal antibody used in this assay recognizes a site that
maps in this region. Moreover, we were unable to coimmuno-
precipitate YY1 even with a polyclonal antibody raised
against intact virions, possibly re£ecting the high immunoge-
nicity of epitopes mapping in the D-E loop ([31], and unpub-
lished results). The argument that the anti-VP1 antibody cov-
ers the YY1 binding site is supported by the results of
immunoprecipitations of lysates of insect SF9 cells co-infected
with baculoviruses expressing YY1 and VP1/VP3: the poly-
omavirus minor capsid protein previously shown to directly
interact with VP1 (11). In fact, anti-VP2/3 speci¢c antibody
immunoprecipitated YY1 only in the presence of VP1 while
no coimmunoprecipitation of VP3 by anti-YY1 antibody was
observed (Fig. 2C).
3.2. Mapping of the interacting domains of VP1 and YY1
To map the VP1 and YY1 domains involved in VP1-YY1
interaction, we resorted to the yeast two-hybrid system (2HS).
Two plasmids, pGBT9-VP1, carrying VP1 fused with the
GAL4 DNA-BD sequences, and pGAD424-YY1, carrying
YY1 sequence fused with the GAL4 AD sequences, were in-
troduced into Saccharomyces cerevisiae strains using the acti-
vation of HIS3 or lacZ gene in order to detect interactions
between the co-produced proteins. Fig. 3 shows the lacZ ex-
pression in yeast colonies producing both YY1 and VP1 pro-
teins and in control yeast cells, transformed with only one
plasmid and producing either the VP1 or the YY1 protein
alone. This showed that YY1 does not activate the expression
of lacZ, while the presence of pGBT9-VP1 alone allows some
expression of the reporter gene. Similar results were obtained
in the S. cerevisiae HF7c strain with the HIS3 reporter gene
(data not shown). However, co-expression of both VP1 and
YY1 genes increased substantially the level of L-galactosidase
production from the lacZ gene. These results showed a direct
interaction between the two proteins despite the existence of a
yeast factor(s) capable of interacting with VP1 and to switch
on the expression of the reporter gene. To determine whether
the VP1 domains involved in the interaction with YY1 and
with the hypothetical yeast factor(s) coincide, we assayed dif-
Fig. 2. Co-immunoprecipitation of VP1, VP3 and YY1 from cells
overexpressing this proteins. A: COS cells transfected with pEB-del-
ta:s expressing YY1, or with pSVL-VP1 expressing VP1, or co-
transfected with both plasmids, respectively. Immunoprecipitation
was performed with anti-YY1 polyclonal antibody or with anti-VP1
monoclonal antibody, as indicated. B: SF9 insect cells infected with
either VL-YY1 or VL-VP1 baculoviruses alone or co-infected with
both of them. Immunoprecipitations were performed with anti-VP1
monoclonal or with anti-YY1 polyclonal antibody. NSA were used
in control immunoprecipitations. C: Insect cells co-infected with
VL-YY1 and VL-VP1, or with VL-YY1 and Ac-VP1-VP3, or with
VL-YY1 and VL-VP3. Immunoprecipitations were performed with
anti-VP2/3B monoclonal or with anti-YY1 polyclonal antibody.
NSA were used in control immunoprecipitations.
Fig. 3. Induction of lacZ expression in the yeast 2H system by in-
teraction of VP1 and YY1. Colony-lift L-galactosidase ¢lter assay of
three and four day old colonies of S. cerevisiae SFY526 expressing
YY1 (co-transformed with pGAD424-YY1 and pGBT9); VP1 (co-
transformed with pGBT9-VP1 and pGAD424); or co-expressing
VP1 and YY1 (co-transformed with pGBT9-VP1 and pGAD424-
YY1).
FEBS 23316 3-2-00
Z. Palkova¤ et al./FEBS Letters 467 (2000) 359^364 361
ferent deletion mutants of VP1 in the 2HS. To this end, two
VP1 mutants carrying a C-terminal deletion obtained through
cleavage of the gene with PstI (VP11ÿ255) or SmaI (VP11ÿ144)
were tested either alone, or in combination with YY1 for the
induction of the expression of lacZ. The results of this assay
(reported in Fig. 4) showed that VP11ÿ255, when tested alone,
behaves like the full length protein, while VP11ÿ144, cleaved
within the D-E loop, reduced substantially the level of the
Fig. 4. Ability of VP1 and YY1 deletion mutants to induce HIS3 or lacZ genes expression. A: Di¡erent VP1 fragments in pGBT9 tested in
yeast 2HS for their ability to induce HIS3 or lacZ gene expression in the absence or presence of YY1. (* very small colonies appeared after
prolonged cultivation). B: Interaction of di¡erent fragments of VP1 protein with YY1 detected by colony-formation induced by HIS3 expres-
sion in S. cerevisiae HF7c. HF7c cells transformed by the plasmids indicated were grown on minimal agar medium in the absence of histidine.
C: Schematic representation of YY1 deletion mutants tested for their ability to induce the HIS3 reporter gene expression in yeast 2HS either
alone (pGBT9) or in the presence of VP1 (pGBT9-VP11ÿ140) as in (A).
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lacZ gene activation; by contrast, in the presence of YY1 the
induction of the reporter gene was not diminished. To map
more precisely the VP1 site that interacts with YY1, deletions
starting from SmaI site (aa 144) of VP1 were generated by
BAL-31 limited digestion and the mutants VP11ÿ140 and
VP11ÿ136 were analyzed in the 2HS. Results reported in Fig.
4A,B show that VP11ÿ140 retains the ability to bind YY1,
although completely looses its interaction with the yeast fac-
tor. VP11ÿ136 shows to be totally unable to activate the re-
porter genes even in presence of YY1, therefore, indicating
that aa 137^140 are required for VP1-YY1 interaction in
this experimental system and that the interacting sites with
the yeast factor and YY1 are distinguishable. Since our pre-
vious results indicated that the D-E loop of VP1 could be
responsible for the viral-host speci¢city [18,19] and may be
involved in the formation of the complex of the viral genome
with the NM (Amati et al., manuscript in preparation), we
fused the sequences encoding the D-E118ÿ170 or the E-F172ÿ248
loops with the GAL4 DNA-BD. The results of the 2HS as in
Fig. 4A,B, show that neither YY1 alone nor VP1 D-E118ÿ170
alone allow the growth of yeast in the absence of histidine in
the medium, while yeast colonies grow e⁄ciently in the pres-
ence of both proteins. Essentially comparable results were
obtained with the lacZ reporter gene induction although the
expression level was lower than that observed with the VP1144
mutant. By contrast, neither HIS3 nor lacZ expression was
observed when VP1 E-F172ÿ248 was tested (Fig. 4 and data not
shown).
Various characterized regions of YY1 protein comprise the
domains involved in repression, activation, DNA binding and
NM association [13,32,33]. To determine the YY1 region(s)
involved in the binding to VP1, YY1 sequences carrying dele-
tions extending from the C or the N terminal ends were ex-
amined for their ability to interact in 2HS with VP11ÿ140, the
minimal fragment that fully interacts with YY1 without being
activated by the yeast factor(s). The YY1 deletion mutants
used, and their respective ability to activate the expression
of HIS3 when co-expressed with VP1 are presented in Fig.
4C. The results show that the interacting sequence of YY1
encompasses aa 1^89, comprising the activation domain.
4. Discussion
In this report we show that the major capsid protein VP1
interacts directly with the host NM protein YY1. The in vivo
detection of this interaction shows to be speci¢c and occurs at
early times after infection in mouse cells, as well as in insect
cells when both proteins are over-expressed. The ¢ne mapping
of VP1 site interacting with YY1, by means of the yeast 2HS,
allows the conclusion that the site on VP1 molecule interact-
ing with YY1 is located into the D-E region (aa 118^170). In
the yeast 2HS we have found that there is a host activator
factor(s) that is able to interact with VP1 fused with GAL4
DNA-BD and to activate HIS3 or lacZ genes. However, no
protein homologous to YY1 has been found by screening of
yeast protein sequences. The activation by the yeast protein
was signi¢cantly lower than that observed when VP1 gene was
co-expressed with YY1 gene fused to GAL4 AD. We also
showed, by the analysis of deletion mutants of VP1 that the
interaction sites of the putative yeast activator factor is lo-
cated in close proximity of the YY1 binding site but can,
nevertheless, be distinguished from the latter. Mapping of
the VP1-BAL31 mutants localized the YY1 binding site
onto the left arm of the D-E loop (aa 118^140), upstream
from that of the yeast factor(s). The fact that D-E118ÿ170 alone
did not exhibit detectable interaction with a yeast factor, while
the VP11ÿ144 mutant retains a reduced ability to switch on the
reporter gene expression, may re£ect a steric interference re-
sulting from the direct interaction between the sequences of
the GAL4 DNA-BD and the D-E118ÿ170 fragment or, alter-
natively, the binding site for the yeast factor includes also
amino acids from the deleted part of VP1 (aa 1^118). We
have demonstrated, in the yeast 2HS, that the interaction of
YY1 with VP1 can occur when VP1 is in monomeric form,
since VP1 fused with the GAL4 DNA-BD does not form
pentamers (our unpublished results).
By deletion mutants of YY1 we have determined that the
interacting region with VP1 is the N terminal encompassing
the ¢rst 89 aa; this region comprises the three activation do-
mains and does not involve the repression domains, the DNA
binding domain nor the sequences devoted to the NM bind-
ing. This ¢nding can be interpreted in di¡erent ways. A pos-
sibility could be that YY1 is involved in targeting the virions
or the viral nucleocore (consisting of viral genome, histones
and capsid proteins [11]) to the appropriate compartment im-
mediately after the virions have reached the cell nucleus. For
example, the YY1-VP1 interactions could be involved in the
viral genome association to the NM, a localization shown to
be essential for expression and replication of some DNA tu-
morigenic viruses, such as polyoma, papillomavirus and ad-
enovirus [8,9,34]. In this context, the role of VP1-YY1 com-
plex resembles that of the adenovirus terminal protein [35].
This possibility is supported by the recent ¢nding that the
amino acids of YY1 responsible for NM interaction are lo-
cated in the C-terminal domain (aa 257^341) [33], i.e. far from
the activation domains we have shown to bind VP1 (aa 1^89);
therefore, a single molecule of YY1 can concomitantly inter-
act with both VP1 and NM.
Another interesting possibility is that the properties of VP1
may also be in£uenced by its interaction with YY1. In this
context, it is worth recalling that VP1 has already been shown
to be a multifunctional protein with several interesting proper-
ties, including binding to the cellular membrane receptor [16],
self-assembling into capsid like structures [36] capable of en-
capsidating heterologous DNA [37,38] and, intriguingly, bind-
ing DNA non-speci¢cally [6,7]. Since YY1 binds DNA in a
speci¢c manner, an additional biological role of VP1-YY1
interaction could be that of conferring DNA binding speci¢c-
ity to VP1. In this regard we should recall that two YY1
consensus sequences are present in the polyoma enhancer
[14], therefore, this could be a mechanism by which the en-
hancer region is found in the virions in a nucleosome-free
con¢guration [1]. These alternatives deserve further investiga-
tion.
The role of YY1 in forming di¡erent complexes with other
cellular proteins so as to regulate gene expression in di¡erent
ways [13], and its possible involvement in viral DNA recom-
bination [39], is subject to extensive research. Our ¢nding that
a viral structural protein interacts with a protein as YY1, that
appears to be a pivotal component of NM regulatory mech-
anisms, support the notion that viral gene expression could be
conditioned not only by its early functions but also by late
structural proteins. To de¢ne the functional role of YY1-VP1
association in the viral life cycle, the biological properties of
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Py-VP1 mutants in the amino acids involved in this interac-
tion are under investigation.
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